Horizon Pharma up today -beat earnings and reaffirms guidanc7:11 am Horizon Pharma beats by $0.03, beats on revs; reaffirms FY16 guidance, announces 5 mln share repurchase (HZNP) : ** HORIZON PHARMA PLC, $15.71, +17.15 pct
The drugmaker reported higher-than-expected Q1 profit and revenue, helped by strong sales of its orphan drugs including Ravicti, Actimmune, Krystexxa and Buphenyl.